Professur für Molekulare Mechanismen der Organfibrose

Hsp90 as a Potential Biomarker of Lung and Skin Involvement in Patients with Systemic Sclerosis (2019) Storkanova H, Oreska S, Spiritovic M, Hermankova B, Bubova K, Komarc M, Pavelka K, et al. Conference contribution The Effect of Nintedanib versus Mycopheolate Mofetil in the FRA2 Mouse Model of Systemic Sclerosis Associated Interstitial Lung Disease (2019) Thuong Trin-Minh , Zhang Y, Distler J, Wollin L Conference contribution EFFICACY OF WNT PATHWAY INHIBITORS FOR THE PREVENTION OF CARDIAC ALLOGRAFT VASCULOPATHY IN A MOUSE MODEL (2019) Kuckhahn A, Ramsperger-Gleixner M, Distler J, Spriewald B, Ensminger S, Weyand M, Heim C Conference contribution Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis (2019) Codullo V, Cova E, Pandolfi L, Breda S, Morosini M, Frangipane V, Malatesta M, et al. Journal article Type 3 Innate Lymphoid Cells in models of psoriasis and psoriatic arthritis (2019) Raimondo MG, Rauber S, Distler J, Schett G, Ramming A Conference contribution Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases (2019) Wollin L, Distler J, Redente EF, Riches DW, Stowasser S, Schlenker-Herceg R, Maher TM, Kolb M Journal article, Review article Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis (2019) Sobanski V, Giovannelli J, Allanore Y, Riemekasten G, Airo P, Vettori S, Cozzi F, et al. Journal article